home All News open_in_new Full Article

DIAGNOS Provides Additional Information on Amendment to Convertible Debentures

BROSSARD, Quebec, April 14, 2025 (GLOBE NEWSWIRE) — Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of certain ophthalmic health issues using advanced technology based on Artificial Intelligence (AI), wishes to provide additional information to the February 28, 2025 announcement on amendment to convertible debentures. […]


today 45 h. ago attach_file Other

attach_file Other
attach_file Economics
attach_file Economics
attach_file Politics
attach_file Economics
attach_file Economics
attach_file Economics
attach_file Other


ID: 1045112590
Add Watch Country

arrow_drop_down